HealthEquity (HQY) Competitors

CDK Global (NASDAQ:CDK) and HealthEquity (NASDAQ:HQY) are both mid-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, community ranking, risk, institutional ownership and earnings.

Do institutionals & insiders hold more shares of CDK or HQY?

92.9% of CDK Global shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.5% of CDK Global shares are held by insiders. Comparatively, 2.2% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has stronger earnings & valuation, CDK or HQY?

CDK Global has higher revenue and earnings than HealthEquity. CDK Global is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CDK Global	$1.67B	3.82	$1.03B	$2.09	26.20
HealthEquity	$1.10B	6.58	$55.71M	$0.92	90.32

Is CDK or HQY more profitable?

CDK Global has a net margin of 14.28% compared to HealthEquity's net margin of 9.61%. CDK Global's return on equity of 67.84% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CDK Global	14.28%	67.84%	11.15%
HealthEquity	9.61%	9.01%	5.73%

Which has more risk & volatility, CDK or HQY?

CDK Global has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500.

Does the MarketBeat Community believe in CDK or HQY?

HealthEquity received 164 more outperform votes than CDK Global when rated by MarketBeat users. Likewise, 69.89% of users gave HealthEquity an outperform vote while only 54.75% of users gave CDK Global an outperform vote.

Company	Underperform	Outperform
CDK Global	Outperform Votes 363 54.75%	Underperform Votes 300 45.25%
HealthEquity	Outperform Votes 527 69.89%	Underperform Votes 227 30.11%

Does the media prefer CDK or HQY?

In the previous week, HealthEquity had 18 more articles in the media than CDK Global. MarketBeat recorded 21 mentions for HealthEquity and 3 mentions for CDK Global. HealthEquity's average media sentiment score of 0.30 beat CDK Global's score of 0.08 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CDK Global	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthEquity	9 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts rate CDK or HQY?

HealthEquity has a consensus target price of $103.83, indicating a potential upside of 24.96%. Given HealthEquity's higher probable upside, analysts clearly believe HealthEquity is more favorable than CDK Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CDK Global	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
HealthEquity	0 Sell rating(s)	0 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

HealthEquity beats CDK Global on 10 of the 17 factors compared between the two stocks.